Our study demonstrated that MYBL2 controls the development of castration resistance and metastatic relapse in PCa by modulating the Hippo-YAP signaling pathway by facilitating RACGAP1-mediated RhoA activation. The gene discussed is YAP1; the disease is posterior cortical atrophy.